Suppr超能文献

细胞色素P450的乙炔基和丙炔基芘抑制剂

Ethynyl and Propynylpyrene Inhibitors of Cytochrome P450.

作者信息

Zhu Naijue, Lightsey Danielle, Liu Jiawang, Foroozesh Maryam, Morgan Kathleen M, Stevens Edwin D, Klein Stevens Cheryl L

机构信息

Department of Chemistry, Xavier University of Louisiana, One Drexel Drive, New Orleans, LA 70125, USA.

出版信息

J Chem Crystallogr. 2010 Apr 1;40(4):343-352. doi: 10.1007/s10870-009-9659-0.

Abstract

The single-crystal X-ray structures and in vivo activities of three aryl acetylenic inhibitors of cytochromes P450 1A1, 1A2, 2A6, and 2B1 have been determined and are reported herein. These are 1-ethynylpyrene, 1-propy-nylpyrene, and 4-propynylpyrene. To investigate electronic influences on the mechanism of enzyme inhibition, the experimental electron density distribution of 1-ethynylpy-rene has been determined using low-temperature X-ray diffraction measurements, and the resulting net atomic charges compared with various theoretical calculations. A total of 82,390 reflections were measured with Mo Kα radiation to a (sinθ/λ)(max) = 0.985 Å(-1). Averaging symmetry equivalent reflections yielded 8,889 unique reflections. A least squares refinement procedure was used in which multipole parameters were added to describe the distortions of the atomic electron distributions from spherical symmetry. A map of the model electron density distribution of 1-ethynylpyrene was obtained. Net atomic charges calculated from refined monopole population parameters yielded charges that showed that the terminal acetylenic carbon atom (C18) is more negative than the internal carbon (C17). Net atomic charges calculated by ab initio, density functional theory, and semi-empirical methods are consistent with this trend suggesting that the terminal acetylenic carbon atom is more likely to be the site of oxidation. This is consistent with the inhibition mechanism pathway that results in the formation of a reactive ketene intermediate. This is also consistent with assay results that determined that 1-ethynylpyrene acts as a mechanism-based inhibitor of P450s 1A1 and 1A2 and as a reversible inhibitor of P450 2B1. Crystallographic data: 1-ethynylpyrene, C(18)H(10), P2(1)/c, a = 14.571(2) Å, b = 3.9094(5) Å, c = 20.242(3) Å, β = 105.042(2)°, V = 1,113.5(2) Å(3); 1-propynylpyrene, C(19)H(12), P2(1)/n, a = 8.970(2) Å, b = 10.136(1) Å, c = 14.080(3) Å, β = 99.77(2)°, V = 1,261.5(4) Å(3); 4-propynylpyrene, C(19)H(12), Pbca, a = 9.904(1) Å, b = 13.174(2) Å, c = 19.401(1) Å, V = 2,531.4(5) Å(3).

摘要

已测定并在此报告了三种细胞色素P450 1A1、1A2、2A6和2B1的芳基乙炔抑制剂的单晶X射线结构及体内活性。它们分别是1-乙炔基芘、1-丙炔基芘和4-丙炔基芘。为了研究电子对酶抑制机制的影响,利用低温X射线衍射测量确定了1-乙炔基芘的实验电子密度分布,并将所得净原子电荷与各种理论计算结果进行比较。用钼Kα辐射共测量了82390个反射,(sinθ/λ)(max)=0.985 Å(-1)。对对称等效反射进行平均得到8889个独立反射。采用最小二乘法精修程序,其中加入多极参数以描述原子电子分布偏离球对称的畸变。得到了1-乙炔基芘的模型电子密度分布图。根据精修的单极布居参数计算得到的净原子电荷表明,末端炔碳(C18)比内部碳(C17)更负。通过从头算、密度泛函理论和半经验方法计算得到的净原子电荷与此趋势一致,表明末端炔碳更可能是氧化位点。这与导致形成活性乙烯酮中间体的抑制机制途径一致。这也与测定结果一致,即1-乙炔基芘是P450 1A1和1A2的基于机制的抑制剂以及P450 2B1的可逆抑制剂。晶体学数据:1-乙炔基芘,C(18)H(10),P2(1)/c,a = 14.571(2) Å,b = 3.9094(5) Å,c = 20.242(3) Å,β = 105.042(2)°,V = 1113.5(2) Å(3);1-丙炔基芘,C(19)H(12),P2(1)/n,a = 8.970(2) Å,b = 10.136(1) Å,c = 14.080(3) Å,β = 99.77(2)°,V = 1261.5(4) Å(3);4-丙炔基芘,C(19)H(12),Pbca,a = 9.904(1) Å,b = 13.174(2) Å,c = 19.401(1) Å,V = 2531.4(5) Å(3)。

相似文献

1
Ethynyl and Propynylpyrene Inhibitors of Cytochrome P450.
J Chem Crystallogr. 2010 Apr 1;40(4):343-352. doi: 10.1007/s10870-009-9659-0.
2
3
Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1.
Chem Res Toxicol. 1998 Sep;11(9):1048-56. doi: 10.1021/tx980090+.
4
7-Ethynylcoumarins: selective inhibitors of human cytochrome P450s 1A1 and 1A2.
Chem Res Toxicol. 2012 May 21;25(5):1047-57. doi: 10.1021/tx300023p. Epub 2012 Apr 10.
5
Suicide inhibitors of cytochrome P450 1A1 and P450 2B1.
Biochem Pharmacol. 1992 Aug 18;44(4):787-96. doi: 10.1016/0006-2952(92)90417-h.
6
Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors.
Chem Res Toxicol. 2007 Mar;20(3):489-96. doi: 10.1021/tx600299p. Epub 2007 Feb 10.
7
Inhibition of cytochrome p450 enzymes by quinones and anthraquinones.
Chem Res Toxicol. 2012 Feb 20;25(2):357-65. doi: 10.1021/tx2004163. Epub 2012 Jan 10.
10
Inhibitory monoclonal antibodies to human cytochrome P450 1A2: analysis of phenacetin O-deethylation in human liver.
Pharmacogenetics. 1998 Oct;8(5):375-82. doi: 10.1097/00008571-199810000-00002.

引用本文的文献

3
Binding of diverse environmental chemicals with human cytochromes P450 2A13, 2A6, and 1B1 and enzyme inhibition.
Chem Res Toxicol. 2013 Apr 15;26(4):517-28. doi: 10.1021/tx300492j. Epub 2013 Mar 13.
4
7-Ethynylcoumarins: selective inhibitors of human cytochrome P450s 1A1 and 1A2.
Chem Res Toxicol. 2012 May 21;25(5):1047-57. doi: 10.1021/tx300023p. Epub 2012 Apr 10.
5
Inhibition of cytochrome p450 enzymes by quinones and anthraquinones.
Chem Res Toxicol. 2012 Feb 20;25(2):357-65. doi: 10.1021/tx2004163. Epub 2012 Jan 10.
6
QSAR models of cytochrome P450 enzyme 1A2 inhibitors using CoMFA, CoMSIA and HQSAR.
SAR QSAR Environ Res. 2011 Oct;22(7-8):681-97. doi: 10.1080/1062936X.2011.623320. Epub 2011 Oct 17.

本文引用的文献

2
Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1.
Chem Res Toxicol. 1998 Sep;11(9):1048-56. doi: 10.1021/tx980090+.
3
4
Introduction: cytochome P450.
FASEB J. 1996 Feb;10(2):205. doi: 10.1096/fasebj.10.2.8641553.
5
The remarkable P450s: a historical overview of these versatile hemeprotein catalysts.
FASEB J. 1996 Feb;10(2):202-4. doi: 10.1096/fasebj.10.2.8641552.
7
Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.
Biochem Pharmacol. 1994 Aug 30;48(5):923-36. doi: 10.1016/0006-2952(94)90363-8.
9
Structure and function of cytochromes P450: a comparative analysis of three crystal structures.
Structure. 1995 Jan 15;3(1):41-62. doi: 10.1016/s0969-2126(01)00134-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验